Katerina Venderova, Pharm.D., Ph.D.
Department of Physiology and Pharmacology
- Molecular pathways in neurodegeneration
- Genetics of Parkinson's disease
- New targets for treatment of neurodegenerative disorders
Dr. Katerina Venderova obtained her master's and doctorate degrees in pharmacy, and her PhD in Toxicology from Charles University in the Czech Republic. She then received a fellowship from the Parkinson Society Canada and pursued her postdoctoral training at Toronto Western Research Institute (2 years), and subsequently at University of Ottawa in Canada (5 years), where she studied genetics of Parkinson's disease, mechanisms of neuronal death and cell signaling in the basal ganglia. Dr. Venderova joined Pacific in 2011.
Hakimi, M., Selvanantham, T., Swinton, E., Padmore, R.F., Tong, Y., Kabbach, G., Venderova, K., Girardin, S.E., Bulman, D.E., Scherzer, C.R., LaVoie, M.J., Gris, D., Park, D.S., Angel, J.B., Shen, J., Philpott, D.J., Schlossmacher, M.G. (2011). Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures. Journal of Neural Transmission May;118(5):795-808. PMID: 21552986
Imai Y, Venderova K, Park DS, Cai H, Schmidt E (2011). Animal models of Parkinson's disease. Parkinsons Dis;2011:364328. PMID: 22220287